Invention Grant
- Patent Title: Albumin-free factor VIII formulations
- Patent Title (中): 新型无白蛋白因子VIII配方
-
Application No.: US13250789Application Date: 2011-09-30
-
Publication No.: US08372800B2Publication Date: 2013-02-12
- Inventor: Marc Besman , Erik Bjornson , Feroz Jameel , Ramesh Kashi , Michael Pikal , Serguei Tchessalov , John Carpenter
- Applicant: Marc Besman , Erik Bjornson , Feroz Jameel , Ramesh Kashi , Michael Pikal , Serguei Tchessalov , John Carpenter
- Applicant Address: US IL Deerfield US CT Farmington
- Assignee: Baxter International Inc.,University of Connecticut
- Current Assignee: Baxter International Inc.,University of Connecticut
- Current Assignee Address: US IL Deerfield US CT Farmington
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/16 ; A61K35/14 ; A61K47/00 ; A61K31/715 ; A61K51/00 ; A01N43/04 ; C07K1/00 ; C07K14/00 ; C07K16/00 ; C07K17/00

Abstract:
An albumin-free Factor VIII formulation comprising: 4% to 10% of a bulking agent selected from the group consisting of mannitol, glycine and alanine; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent. Alternatively, the formulation can comprise 2% to 6% hydroxyethyl starch; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent. In a further embodiment, the formulation can comprise: 300 mM to 500 mM NaCl; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; and a buffering agent.
Public/Granted literature
- US20120083446A1 NOVEL ALBUMIN-FREE FACTOR VIII FORMULATIONS Public/Granted day:2012-04-05
Information query
IPC分类: